FYMRALIN
Live / Applied — Second extension granted (statement of use) (as of 22 Oct 2025)
What this means for you
Not registered yet, but its 22 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98327953
- Mark type
- Stylized text
- Filed
- 22 Dec 2023
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Francis J. Duffin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders
Owner
- TONIX PHARMACEUTICALS, INC., Chatham, NJ, US
- TONIX PHARMACEUTICALS, INC., Chatham, NJ, US
Prosecution history
- 23 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2025 — SOU EXTENSION 2 GRANTED
- 22 Oct 2025 — SOU EXTENSION 2 FILED
- 22 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2024 — SOU EXTENSION 1 GRANTED
- 24 Oct 2024 — SOU EXTENSION 1 FILED
- 24 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION
- 07 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jul 2024 — ASSIGNED TO EXAMINER
- 04 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED